In recent years, the requirements for employee protection have increased significantly. On the one hand, this is due to highly active pharmaceutical ingredients (HAPI), and on the other hand, it is due to ever-improving safety regulations and thus an increasing awareness of how important safety is for employees and the end consumer. Our experts in the field of highly potent substances can advise you on the safest way to implement processes for handling such substances.
For this purpose, substances are divided into OEB levels, which describe the maximum permissible dust exposure per cubic meter of air breathed. Here it is particularly important to adapt dynamically to the continuously improved safety standards of pharmaceutical companies.
Due to our broad experience, we can accompany and support you in projects from laboratory to production scale. Our specialties are the planning and implementation of isolator and RABS systems, the planning of ventilation and airlock concepts for secondary containment as well as primary containment for HAPI and sterile fillings. You benefit from tailor-made solutions, which are always developed in a cost-conscious manner in a GMP-regulated environment.
- Planning of a new filling plant, swissfillon AG, Visp (CH)
- Development and coordination of a cytotoxic filling plant with lyophilization, confidential
- Development of an overall concept for a mAb multi-product plant, confidential
- Planning and execution of a HAPI mono and multi-product plant for API, Lonza AG, Visp (CH)